Congratulations to Work Package 7 working group for publishing some of the work carried out as part of SOPHIA. The research highlights the lived experiences of people living with obesity during the COVID-19 pandemic. It highlights the challenge sustaining treatment and psychosocial impact during these unprecedented times.

The research article was published on the 4th of Sep in Clinical Obesity, click here for full access.

The project is funded by a grant from the Innovative Medicines Initiative (IMI) – a joint undertaking of the European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA); JDRF (formerly the Juvenile Diabetes Research Foundation); the Obesity Action Coalition; and T1D Exchange.

About IMI

The Innovative Medicines Initiative (IMI) is Europe’s largest public-private initiative aiming to improve health by speeding up the development of, and patient access to, innovative medicines, particularly in areas where there is an unmet medical or social need. IMI facilitates collaboration between the key players involved in healthcare research, including universities, the pharmaceutical and other industries, small and medium-sized enterprises (SMEs), patient organisations, and medicines regulators. It is a partnership between the European Union (represented by the European Commission) and the European pharmaceutical industry (represented by EFPIA, the European Federation of Pharmaceutical Industries and Associations). For further information: www.imi.europa.eu

 

The Innovative Medicine Initiative has published an article about the work we do in SOPHIA and it impacts on the diabetes epidemic. The article includes a Q&A with Prof Carel le Roux, Project Coordinator.

Full article available on the IMI’s website, press here. 

The COVID-19 pandemic has caused many events around the world to be cancelled or postponed and SOPHIA also had its share. SOPHIA’s Kick-Off meeting was originally planned to take place in Denmark last month but it had to be postponed to a later ‘yet to be confirmed’ date.

Prof Carel le Roux, Coordinator of SOPHIA, spoke on Irish Radio NEAR fm about the SOPHIA project and how it aims to change the treatments of obesity. 

New €16 million EU and industry-supported international research consortium aims to improve obesity treatment and change the narrative around obesity